| 1 |
HURA
|
biotech
healthcare
|
TuHURA Biosciences, Inc.
|
12.2x
|
0.25
|
TuHURA is a high-fragility, high-convexity micro-cap biotech: if IFx-2.0 reaches approval in a rare-cancer niche and management converts TBS-2025 and the DOR assets into partner-funded follow-ons, the company can grow from zero revenue to a meaningful orphan-oncology franchise by 2031 despite heavy dilution risk.
|
| 2 |
MSTR
|
ai
crypto
enterprise
finance
software
|
Strategy Inc
|
7.4x
|
0.40
|
The 5-year upside is driven mainly by Strategy continuing to turn public-market demand into more bitcoin per share while keeping its reserve and preferred stack credible; software matters less as a value driver but can protect downside and create optional higher-quality revenue if AI governance products gain traction.
|
| 3 |
APUS
|
ai
biotech
crypto
finance
healthcare
|
Apimeds Pharmaceuticals US, Inc.
|
6.8x
|
0.20
|
APUS is a low-base-rate option on one thing becoming financeable: if May 2026 FDA feedback turns LT-100 into a partnerable U.S. program, the company can monetize rights, fund the next study with less dilution, and layer in small but real treasury-workflow revenue; if not, the equity likely remains trapped in serial recapitalizations.
|
| 4 |
SERV
|
ai
automation
healthcare
robotics
transportation
|
Serve Robotics Inc.
|
6.4x
|
0.60
|
Serve has a real non-linear setup because it already owns live robot operations, partner distribution, and a growing data flywheel; if it converts deployed robots into high-utilization, outcome-priced delivery and healthcare workflows, revenue can scale far faster than headcount, but the bottleneck is monetization density, not robot count.
|
| 5 |
AISP
|
ai
defense
enterprise
hardware
software
|
Airship AI Holdings, Inc.
|
6.2x
|
0.58
|
Airship can turn a tiny installed base and federal trust posture into a much larger secure edge-video workflow business if it converts pipeline into repeat awards and shifts value capture from one-off projects toward recurring mission assurance, evidence, and compliance layers.
|
| 6 |
NTLA
|
biotech
healthcare
|
Intellia Therapeutics, Inc.
|
6.2x
|
0.40
|
If HAELO succeeds, Intellia can jump from collaboration revenue to a real rare-disease franchise led by a one-time HAE therapy, with ATTR recovery and smarter contracting adding upside; the bet is less on AI software and more on turning regulated biological proof into durable product economics.
|
| 7 |
NNOX
|
ai
cloud
healthcare
medical devices
software
|
Nano-X Imaging Ltd.
|
5.9x
|
0.46
|
Nanox has a real shot at compounding from a low base if it turns regulatory progress and distributor expansion into active sites that generate recurring scan, reading, and workflow revenue; the upside is meaningful, but the equity outcome is capped by financing needs and still-unproven deployment economics.
|
| 8 |
RXRX
|
ai
automation
biotech
healthcare
software
|
Recursion Pharmaceuticals, Inc.
|
5.8x
|
0.60
|
Recursion is a discounted AI-biotech factory, not a thin software wrapper: if it converts proprietary wet-lab data and compute into one registrationally credible asset, a second human-proof asset, and more embedded partner monetization by 2031, equity value can compound meaningfully from today's depressed base.
|
| 9 |
SDGR
|
ai
biotech
enterprise
healthcare
software
|
Schrödinger, Inc.
|
5.5x
|
0.50
|
Over the next five years, Schrödinger can turn a noisy hosted-transition period into a better business: a stickier discovery operating layer with improving software quality, selective trust-based monetization, and capital-light royalty upside.
|
| 10 |
AI
|
ai
automation
defense
enterprise
software
|
C3.ai, Inc.
|
5.4x
|
0.35
|
C3 AI is not an AI primitive winner, but it is a mispriced regulated-workflow option: if the reset converts federal and industrial pilots into repeatable production subscriptions and trusted control-layer revenue, equity upside can be meaningful from a depressed base.
|
| 11 |
PRME
|
ai
biotech
healthcare
|
Prime Medicine, Inc.
|
5.2x
|
0.40
|
Prime Medicine is a high-risk platform biotech where real value can inflect non-linearly if PM359 secures a credible approval path, Wilson disease and AATD reach clinic on schedule, and the company turns liver-platform validation into repeatable licensing plus future product revenue before financing pressure forces value-destructive dilution.
|
| 12 |
RR
|
ai
automation
enterprise
hardware
robotics
|
Richtech Robotics Inc.
|
5.2x
|
0.40
|
Richtech’s 5-year upside comes from turning an unusually cash-rich microcap robot vendor into a repeatable installed-base operator: if it proves multi-site RaaS deployments, standardized Dex industrial cells, and attachable data/services revenue, revenue can grow non-linearly from a tiny base; if not, the stock remains an expensive prototype on public markets.
|
| 13 |
RLAY
|
ai
biotech
healthcare
|
Relay Therapeutics, Inc.
|
4.8x
|
0.40
|
Relay is a focused precision-oncology option on zovegalisib: if the March 16, 2026 Phase 3-dose dataset and subsequent pivotal execution confirm a cleaner, durable PI3Kα profile, one asset can become a multisetting breast-cancer plus vascular-anomalies franchise while Dynamo lifts follow-on odds. That supports 2-5x equity value by 2031, with sharp downside if validation breaks.
|
| 14 |
BEAM
|
ai
biotech
healthcare
|
Beam Therapeutics Inc.
|
4.7x
|
0.40
|
Beam is a high-convexity clinical-stage gene-editing company whose upside comes from turning base editing into repeatable product approvals, with risto-cel and BEAM-302 as the two proof points that can rerate it from cash-backed platform science to a multi-asset rare-disease franchise by 2031.
|
| 15 |
AUR
|
ai
automation
robotics
software
transportation
|
Aurora Innovation, Inc.
|
4.6x
|
0.65
|
Aurora can turn early driverless trucking proof into a trusted freight-capacity network; if it clears 2026 hardware, fleet, and permissioning gates, value capture should shift from 'autonomy software' to scarce, contracted, high-utilization linehaul capacity embedded in carrier workflows.
|
| 16 |
CRSP
|
biotech
healthcare
|
CRISPR Therapeutics AG
|
4.2x
|
0.40
|
CRISPR Therapeutics has moved beyond pure platform promise: if CASGEVY keeps scaling and 2026-2027 validates at least one owned in vivo program plus one immune franchise, the stock can rerate from a cash-backed single-asset story to a real multi-franchise gene-editing company by 2031.
|
| 17 |
OUST
|
ai
automation
hardware
robotics
software
|
Ouster, Inc.
|
4.0x
|
0.40
|
Ouster can outgrow lidar peers if it converts a sensor installed base into a broader sensing-and-perception stack for robots, warehouses, intersections, and secure sites; StereoLabs makes that path more credible, but the equity case now depends on proving repeat software attach and durable mix improvement after one-time royalties roll off.
|
| 18 |
MBLY
|
ai
automation
automotive
semiconductors
software
|
Mobileye Global Inc.
|
4.0x
|
0.60
|
Mobileye is a rare auto-tech asset where depressed valuation meets real embedded distribution: if EyeQ6-based Surround ADAS, SuperVision, and early robotaxi launches turn sourced wins into production revenue, it can evolve from a camera-led ADAS supplier into a higher-content autonomy platform without needing robotaxi-scale perfection.
|
| 19 |
QUBT
|
communications
cybersecurity
hardware
quantum
semiconductors
|
Quantum Computing Inc.
|
3.9x
|
0.40
|
QCi is a funded option on turning a real U.S. photonics stack into a trusted supply and security business; if foundry utilization, acquired component revenue, and AI interconnect and secure communications wins compound together, revenue can reach meaningful scale by 2031, but the thesis only works if commercialization becomes repeatable soon.
|
| 20 |
POET
|
ai
communications
hardware
networking
semiconductors
|
POET Technologies Inc.
|
3.9x
|
0.60
|
POET is a high-beta commercialization story in AI optics: if its Optical Interposer moves from demos, samples, and first orders into qualified recurring sockets, revenue can scale non-linearly from a tiny base; if not, today’s valuation already reflects too much of that future.
|
| 21 |
PDYN
|
aerospace
ai
automation
defense
software
|
Palladyne AI Corp.
|
3.8x
|
0.60
|
PDYN can grow into a meaningfully larger defense-autonomy supplier if it turns backlog, acquired avionics/manufacturing assets, and early IQ and swarm deployments into repeat OEM and program revenue; the non-linear upside is becoming the embedded trust-and-integration layer inside drones and defense industrial automation rather than a thin AI software wrapper.
|
| 22 |
S
|
ai
cloud
cybersecurity
enterprise
software
|
SentinelOne, Inc.
|
3.8x
|
0.58
|
SentinelOne has a credible five-year path to compound faster than software market norms by turning strong endpoint footing into broader platform adoption across cloud, identity, data, and AI-security workflows; the upside comes from cross-sell and margin expansion, while the main cap is bundled competition from larger security suites.
|
| 23 |
DNA
|
ai
automation
biotech
healthcare
|
Ginkgo Bioworks Holdings, Inc.
|
3.6x
|
0.42
|
The five-year upside is a category shift from bespoke cell-engineering work to contracted autonomous-lab capacity, customer-site installs, and data-enhanced biology tools; if Ginkgo proves repeatable utilization before cash pressure forces dilution, the equity can rerate from distressed tools economics to a credible TechBio utility.
|
| 24 |
WULF
|
ai
cloud
crypto
energy
|
TeraWulf Inc.
|
3.6x
|
0.74
|
TeraWulf is a leveraged bet that scarce U.S. grid-connected campuses become more valuable than generic data center shells; if management converts Lake Mariner, Abernathy, and the new power sites into repeatable, credit-backed AI leases without fresh dilution, revenue can scale non-linearly and the stock can still compound meaningfully.
|
| 25 |
IONQ
|
cloud
defense
hardware
networking
quantum
|
IonQ, Inc.
|
3.6x
|
0.64
|
IonQ can grow into a larger sovereign and enterprise quantum infrastructure vendor if it converts backlog into repeat revenue, closes the SkyWater path, and monetizes compute plus networking/security together; that can still drive a 2-3x equity outcome by 2031 despite a rich starting valuation.
|
| 26 |
COIN
|
crypto
enterprise
finance
software
|
Coinbase Global, Inc.
|
3.5x
|
0.70
|
Coinbase can compound from a cyclical crypto broker into the leading regulated onchain financial utility: if it keeps pulling assets onto trusted rails and monetizes them through Prime, USDC, Base, payments, and new asset classes, revenue can scale much faster than the market still anchored to exchange-only economics expects.
|
| 27 |
ACHR
|
aerospace
automation
defense
evtol
transportation
|
Archer Aviation Inc.
|
3.5x
|
0.60
|
Archer is one of the few eVTOL names with enough cash, certification progress, manufacturing setup and launch partners to plausibly turn a concept market into a real one by 2031; the upside is not from software-like hyper-scale, but from clearing FAA gates, ramping Midnight output and layering defense, services and airport-linked distribution on top of the aircraft sale.
|
| 28 |
IREN
|
ai
cloud
crypto
energy
|
IREN Limited
|
3.3x
|
0.68
|
IREN is a scarce-power developer masquerading as a miner: if it keeps converting secured campuses into contracted AI capacity and funds that growth with asset-backed capital rather than repeated equity, revenue can scale toward 8000 by 2031 and equity value can still compound at a low-20s rate despite multiple compression.
|
| 29 |
SOUN
|
ai
automation
automotive
enterprise
software
|
SoundHound AI, Inc.
|
3.3x
|
0.40
|
SoundHound can become a meaningful multi-vertical workflow layer for voice and agentic automation if it keeps shifting value capture from generic software seats toward embedded usage, verified actions, and trusted enterprise control points; the business can scale fast, but the stock already prices in a large share of that promise.
|
| 30 |
SPIR
|
aerospace
defense
software
space
|
Spire Global, Inc.
|
3.3x
|
0.60
|
Spire can grow into a strategically valuable Earth-intelligence and mission-operations asset if it converts contracted backlog, preserves cash discipline, and shifts more of its offering from raw orbital data toward verified decision workflows that AI makes more useful rather than less valuable.
|
| 31 |
SMR
|
automation
energy
hardware
nuclear
|
NuScale Power Corporation
|
3.3x
|
0.67
|
NuScale is a leveraged call option on AI-era power scarcity because it owns a rare licensed SMR design and can stay relatively asset-light, but the re-rate requires at least one U.S. project and one second geography to convert from partner momentum into binding revenue.
|
| 32 |
BFLY
|
ai
hardware
healthcare
medical devices
software
|
Butterfly Network, Inc.
|
3.2x
|
0.50
|
Butterfly can compound if it turns handheld ultrasound from a device sale into a low-cost wedge for enterprise workflow, trust, and embedded licensing; the non-linear upside comes from software, governance, and partner royalties, not just more probes.
|
| 33 |
ESTC
|
ai
cloud
cybersecurity
enterprise
software
|
Elastic N.V.
|
3.2x
|
0.60
|
Elastic is a reasonably aligned AI-era data layer: if it converts today’s AI interest into durable cloud consumption and cross-sell, it can grow into a larger search, observability, security, and agent-governance rail while rerating from a discounted infrastructure multiple rather than needing a heroic narrative.
|
| 34 |
QBTS
|
cloud
enterprise
hardware
quantum
software
|
D-Wave Quantum Inc.
|
3.2x
|
0.54
|
D-Wave is one of the few public quantum companies with shipped hardware, cloud delivery, and enough cash to press its roadmap; if 2026-2028 turns marquee bookings into repeatable production optimization contracts while the gate-model push becomes real, revenue can scale non-linearly, but the stock already requires commercial proof rather than science alone.
|
| 35 |
NBIS
|
ai
cloud
enterprise
hardware
software
|
Nebius Group N.V.
|
3.1x
|
0.78
|
Nebius is a leveraged bet on scarce AI capacity: if it converts contracted power and NVIDIA-backed supply into connected, highly utilized campuses, it can scale from a subscale AI cloud into a multi-billion-dollar infrastructure platform with enough workflow and trust layers to keep a premium valuation.
|
| 36 |
INOD
|
ai
enterprise
healthcare
media
software
|
Innodata Inc.
|
3.1x
|
0.44
|
Innodata can compound well above normal IT-services peers if it converts hyperscaler-led data-engineering demand into broader, stickier AI evaluation and assurance revenue, but the upside depends on reducing single-customer concentration and capturing more value through embedded workflow control points rather than project labor alone.
|
| 37 |
JOBY
|
aerospace
automation
defense
evtol
transportation
|
Joby Aviation, Inc.
|
3.1x
|
0.58
|
If Joby converts its certification lead into first live routes and then a credible factory ramp, it can move from a development story to a regulated mobility stack with service, aircraft, support and defense revenue. The non-linearity comes from scarce approvals, airport access and learning-curve advantages rather than software alone.
|
| 38 |
RGTI
|
ai
cloud
hardware
quantum
semiconductors
|
Rigetti Computing, Inc.
|
3.1x
|
0.40
|
Rigetti is a high-beta option on useful quantum infrastructure: if 108-qubit validation turns chiplet progress into repeat sovereign installs, verified cloud usage, and Fab-1 learning loops, revenue can scale sharply from a tiny base by 2031; but because the stock already prices in a lot of success, likely shareholder upside is closer to 2-3x than venture-style 10x.
|
| 39 |
RCAT
|
aerospace
automation
defense
hardware
robotics
|
Red Cat Holdings, Inc.
|
3.0x
|
0.60
|
Red Cat has a real shot to turn trusted U.S.-made drone access into a much larger defense robotics business, but shareholder upside now depends on converting procurement wins into repeatable, profitable delivery volume because the stock already discounts a lot of success.
|
| 40 |
AMBA
|
ai
automotive
hardware
robotics
semiconductors
|
Ambarella, Inc.
|
3.0x
|
0.56
|
Ambarella is a leveraged physical-AI pick: if its low-power vision chips, tooling and selective semi-custom work convert more design wins into production across auto, security and robotics, revenue can nearly triple by 2031 while the market still values it more like a niche chip vendor than a scaled edge-AI control point.
|
| 41 |
AMPX
|
aerospace
defense
energy
hardware
transportation
|
Amprius Technologies, Inc.
|
2.9x
|
0.60
|
Amprius can still compound meaningfully if it turns a real battery-performance edge into repeat defense and aviation volume through partner manufacturing; the AI/autonomy era increases the value of flight time, weight savings, and trusted sourcing, but upside now depends more on clean scale-up and margin durability than on chemistry novelty alone.
|
| 42 |
TEM
|
ai
biotech
healthcare
medical devices
software
|
Tempus AI, Inc.
|
2.9x
|
0.60
|
Tempus can turn diagnostics scale into a governed clinical-data and workflow moat: if oncology, hereditary, and monitoring volume keep compounding while data and applications become a larger mix, the business can outgrow diagnostics peers and still merit a premium multiple even without pure-software economics.
|
| 43 |
RDVT
|
ai
cybersecurity
enterprise
software
|
Red Violet, Inc.
|
2.9x
|
0.60
|
red violet is a profitable identity-intelligence tollbooth: as AI agents create more onboarding, fraud, and counterparty checks, verification demand should rise, and if the company keeps shifting from lookup tools toward embedded decisioning, it can compound faster than a typical micro-cap software name; the main cap on upside is supplier-controlled data rights.
|
| 44 |
CRWV
|
ai
cloud
enterprise
hardware
software
|
CoreWeave, Inc.
|
2.8x
|
0.78
|
CoreWeave is one of the few public equities directly monetizing scarce AI power, GPU capacity, and deployment speed; if it converts contracted capacity into durable revenue while lifting software and financing quality, it can grow into a much larger platform, but the equity outcome remains gated by capital intensity and backlog conversion.
|
| 45 |
PATH
|
ai
automation
cloud
enterprise
software
|
UiPath, Inc.
|
2.8x
|
0.38
|
UiPath can turn a mature bot-automation franchise into a governed execution layer for agents, apps, and people; if that shift improves ARR durability and pricing mix, modest revenue growth plus multiple repair can still produce a solid 5-year equity outcome.
|
| 46 |
SMCI
|
ai
cloud
enterprise
hardware
networking
|
Super Micro Computer, Inc.
|
2.8x
|
0.64
|
Supermicro is a leveraged AI infrastructure beneficiary because it turns new silicon into deployable liquid-cooled racks faster than many rivals; if it converts that speed into broader services, better billing terms, and lower customer concentration, equity value can compound even without a software-like valuation.
|
| 47 |
CORZ
|
ai
cloud
crypto
energy
|
Core Scientific, Inc.
|
2.8x
|
0.65
|
Core Scientific has a real chance to turn a former bitcoin miner’s power footprint into a scarce AI-campus platform: if it completes the 590 MW CoreWeave ramp, wins at least one more anchor tenant, and shifts financing to repeatable project structures, revenue quality can inflect enough to drive a 2-3x equity outcome by 2031 despite heavy capital needs.
|
| 48 |
ALAB
|
ai
cloud
hardware
networking
semiconductors
|
Astera Labs, Inc.
|
2.8x
|
0.70
|
Astera Labs is a real AI infrastructure enabler with room to grow revenue far faster than the broader semiconductor market as content per rack expands from retimers into switches, cables, custom links and software-attached operations; the catch is that shareholder upside is constrained by customer concentration, qualification gates and a valuation that already prices in major success.
|
| 49 |
FIVN
|
ai
cloud
communications
enterprise
software
|
Five9, Inc.
|
2.8x
|
0.35
|
Five9 is a cheap, cash-generative control point in enterprise customer-service workflows; if it shifts monetization from human seats toward AI usage, trust, and partner-led orchestration, it can outgrow current expectations and earn a better multiple over five years.
|
| 50 |
BBAI
|
ai
automation
defense
enterprise
software
|
BigBear.ai Holdings, Inc.
|
2.7x
|
0.40
|
BigBear.ai can evolve from a lumpy federal contractor into a higher-multiple secure AI workflow vendor if Ask Sage, CargoSeer, and identity tools become embedded in regulated missions; that supports several-fold upside by 2031, but only if software mix rises fast enough to outrun procurement delays and model-cost compression.
|
| 51 |
ZS
|
cloud
cybersecurity
enterprise
networking
software
|
Zscaler, Inc.
|
2.7x
|
0.65
|
Zscaler can grow from a zero-trust access vendor into a broader enterprise trust and policy layer for users, workloads, branches, data, browsers, and AI activity; if regulated-market sovereignty and newer modules keep attaching, revenue can roughly double over five years without needing a heroic rerating.
|
| 52 |
CRDO
|
ai
hardware
networking
semiconductors
|
Credo Technology Group Holding Ltd
|
2.7x
|
0.66
|
Credo is a real AI infrastructure winner because low-power, reliability-heavy interconnect becomes more valuable as clusters scale, but the stock already prices in much of the AEC boom; the next leg depends on proving optics, PCIe/CXL and attached control-layer workflows can broaden revenue and defend margins beyond a few giant customers.
|
| 53 |
FLNC
|
ai
automation
energy
enterprise
software
|
Fluence Energy, Inc.
|
2.7x
|
0.60
|
Fluence is a credible AI-power picks-and-shovels name: if it converts record backlog into on-time deliveries and shifts more value capture toward software, services, and operating outcomes, the equity can compound well above market rates without needing heroic market-share gains.
|
| 54 |
APLD
|
ai
cloud
crypto
energy
hardware
|
Applied Digital Corporation
|
2.7x
|
0.66
|
Applied Digital is a levered way to own scarce AI campus capacity: if it keeps converting signed megawatts into live service while reducing financing friction, revenue can scale non-linearly from contracted leases, new campuses, and higher-value power and trust layers, though the upside is capped by power delivery and external capital.
|
| 55 |
BKSY
|
ai
defense
software
space
|
BlackSky Technology Inc.
|
2.7x
|
0.60
|
BlackSky can more than double enterprise value by 2031 if Gen-3 shifts the business from lumpy imagery sales into recurring assured-access and sovereign intelligence contracts, because in an AI-heavy world trusted collection rights and mission integration should stay scarcer than analytics alone.
|
| 56 |
NOW
|
ai
automation
cloud
enterprise
software
|
ServiceNow, Inc.
|
2.7x
|
0.68
|
ServiceNow is well placed to turn from a workflow app suite into the governed execution layer for enterprise AI, so the realistic upside is sustained large-cap compounding from installed-base AI attach, security expansion, and partner-led distribution rather than a speculative moonshot.
|
| 57 |
OKLO
|
ai
defense
energy
healthcare
nuclear
|
Oklo Inc.
|
2.6x
|
0.74
|
Oklo owns scarce AI-era bottlenecks—permissioned nuclear sites, first-core fuel access, and an owner-operator model—but from a rich starting valuation the five-year win likely comes from turning those assets into repeatable contracted projects, not from narrative alone.
|
| 58 |
RIOT
|
ai
cloud
crypto
energy
hardware
|
Riot Platforms, Inc.
|
2.6x
|
0.60
|
Riot owns scarce approved Texas power and enough in-house electrical capability to turn a cyclical bitcoin miner into a hybrid compute-infrastructure landlord; if AMD is the first repeatable proof point rather than a one-off, the stock can compound meaningfully even without a heroic AI buildout.
|
| 59 |
CRNC
|
ai
automotive
enterprise
software
transportation
|
Cerence Inc.
|
2.6x
|
0.50
|
Cerence is a cheap embedded automotive AI distribution asset: if it converts xUI from demo traction into production launches, raises software content per vehicle, and keeps de-risking the balance sheet, revenue can roughly double by 2031 and equity can compound meaningfully from a depressed base.
|
| 60 |
HUT
|
ai
cloud
crypto
energy
|
Hut 8 Corp.
|
2.5x
|
0.63
|
Hut 8 can evolve from a miner with optionality into a scarce-power infrastructure platform if it converts River Bend and at least one follow-on campus into financed, long-duration AI cash flows; the nonlinear upside comes from proving its pipeline is repeatable and fundable, not just large on paper.
|
| 61 |
TWST
|
ai
automation
biotech
healthcare
|
Twist Bioscience Corporation
|
2.5x
|
0.56
|
Twist is a leveraged pick on AI-driven biology volume: as design gets cheaper, more value shifts to the trusted factory that screens, manufactures and validates DNA at scale. The stock can roughly double by 2031 if management converts that manufacturing edge into stickier regulated, OEM and workflow-embedded revenue rather than staying a transactional tools vendor.
|
| 62 |
ASTS
|
communications
defense
hardware
networking
space
|
AST SpaceMobile, Inc.
|
2.5x
|
0.72
|
If AST converts its 2026 launch, approval and activation gates into live carrier service, it can turn a hard-to-copy orbital network into multi-billion recurring wholesale revenue; the upside is nonlinear because scarce coverage, government demand and contract-backed capacity can scale far faster than today’s revenue base, though the stock already prices in meaningful success.
|
| 63 |
LMND
|
ai
automotive
finance
software
|
Lemonade, Inc.
|
2.5x
|
0.50
|
Lemonade can still compound meaningfully if its AI-led acquisition, pricing, and claims stack converts fast premium growth into durable gross profit, but the payoff is insurer-like rather than pure-software-like because regulation, reinsurance, and price competition remain binding.
|
| 64 |
AMD
|
ai
cloud
hardware
semiconductors
software
|
Advanced Micro Devices, Inc.
|
2.4x
|
0.74
|
AMD is a strong Last Economy beneficiary because it sells scarce compute inputs and now has a credible rack-scale AI platform; if it converts Meta, OpenAI and enterprise wins into repeatable deployments while EPYC keeps taking share, revenue can compound far faster than a normal large-cap semiconductor name.
|
| 65 |
DDOG
|
ai
cloud
cybersecurity
enterprise
software
|
Datadog, Inc.
|
2.4x
|
0.62
|
Datadog can turn AI-driven software sprawl into a larger control-plane business: more telemetry, more incidents, and more security workflows drive usage, while governance and automation products shift value capture from raw ingest toward trusted operational decisions.
|
| 66 |
SNOW
|
ai
cloud
enterprise
software
|
Snowflake Inc.
|
2.4x
|
0.68
|
Snowflake can compound value by becoming the governed control layer where enterprise data, apps, and AI agents run together; if AI shifts from demos to production consumption on-platform, revenue can outgrow the broader software market without needing seat-based pricing.
|
| 67 |
SYM
|
ai
automation
hardware
robotics
software
|
Symbotic Inc.
|
2.4x
|
0.60
|
Symbotic can still create attractive 5-year equity value if it turns its very large contracted backlog into a bigger installed base, lifts recurring software and service revenue, and uses Walmart-funded adjacencies plus Fox to diversify faster than valuation compresses.
|
| 68 |
TSLA
|
ai
automotive
energy
robotics
transportation
|
Tesla, Inc.
|
2.4x
|
0.72
|
Tesla can still roughly double equity value by 2031 if energy, autonomy-adjacent services and early robotics turn its installed hardware base into recurring cash flows; the stock no longer needs perfect robotaxi dominance, but it does need proof that heavy capex converts into real utilization.
|
| 69 |
AAOI
|
ai
communications
hardware
networking
semiconductors
|
Applied Optoelectronics, Inc.
|
2.3x
|
0.63
|
AOI is a real AI-optics beneficiary because qualified laser and transceiver output is scarce, but the stock already prices in a large share of that scarcity; over five years the likely win is strong revenue scaling with a sharp valuation normalization, producing solid rather than explosive equity upside.
|
| 70 |
CRM
|
ai
automation
cloud
enterprise
software
|
Salesforce, Inc.
|
2.3x
|
0.63
|
Salesforce can turn a maturing seat-led CRM base into a higher-value workflow, data, and trust layer for enterprise AI; if Agentforce, Data Cloud, Slack, and Informatica attach broadly across the installed base, revenue can compound into the low teens and enterprise value can roughly double without requiring a heroic rerating.
|
| 71 |
APP
|
advertising
ai
media
software
|
AppLovin Corporation
|
2.3x
|
0.60
|
AppLovin is a rare ad-tech asset where AI improves the core money engine rather than commoditizing it; if Axon expands from gaming into commerce and CTV while the company keeps its take-rate economics and buyback cadence, the business can still compound strongly even with a lower exit multiple.
|
| 72 |
ORCL
|
ai
cloud
enterprise
healthcare
software
|
Oracle Corporation
|
2.3x
|
0.72
|
Oracle can turn its database-and-ERP installed base into a capital-intensive but durable AI utility: if OCI capacity, financing, and multicloud database conversion stay on track, revenue can roughly double by 2031 while the mix shifts toward harder-to-disintermediate infrastructure and governed execution.
|
| 73 |
AVAV
|
aerospace
ai
defense
robotics
space
|
AeroVironment, Inc.
|
2.3x
|
0.60
|
AeroVironment is evolving from a drone specialist into a broader defense-autonomy platform: if it converts funded backlog, digests BlueHalo, and layers trusted mission software, assurance, and allied production onto validated hardware, it can grow into a much larger all-domain supplier without needing heroic market-share assumptions.
|
| 74 |
VICR
|
ai
automation
energy
hardware
semiconductors
|
Vicor Corporation
|
2.3x
|
0.72
|
Vicor is a leveraged pick on AI power-density bottlenecks: if it turns superior module technology plus IP enforcement into a broader rack-power architecture and royalty stream, revenue can compound far faster than normal analog peers, though the ceiling is set by fab expansion and a few large customer ramps.
|
| 75 |
MRVL
|
ai
communications
hardware
networking
semiconductors
|
Marvell Technology, Inc.
|
2.2x
|
0.70
|
Marvell is a leveraged AI infrastructure supplier: if it keeps key hyperscaler custom-silicon roadmaps and broadens attach into optics, switching and memory connectivity, revenue can more than double by 2031; the main limits are buyer concentration, supplier-controlled capacity and some normalization in valuation.
|
| 76 |
NTRA
|
ai
biotech
healthcare
software
|
Natera, Inc.
|
2.2x
|
0.60
|
Natera can still compound at a bull-leaning rate if Signatera evolves from a fast-growing assay into a covered oncology workflow standard, with AI improving assay performance and lab efficiency while enterprise contracts and pharma-linked economics lift value capture beyond simple per-test volume.
|
| 77 |
LSCC
|
ai
automation
cybersecurity
hardware
semiconductors
|
Lattice Semiconductor Corporation
|
2.2x
|
0.60
|
Lattice can outgrow the broader FPGA market because AI servers, industrial automation, and security-critical systems need more low-power programmable control silicon; if 2026 rebound, new-product mix, and secure-control attach rates convert into production ramps, revenue can reach roughly 2050 by 2031 even with valuation multiple compression.
|
| 78 |
META
|
advertising
ai
communications
hardware
media
|
Meta Platforms, Inc.
|
2.2x
|
0.81
|
Meta is a high-quality AI compounding story: cheaper cognition strengthens ranking, engagement, and ad yield on owned surfaces, while WhatsApp, Threads, commerce rails, and wearables add upside; the key debate is whether regulation and giant AI capex let that value reach shareholders by 2031.
|
| 79 |
STEM
|
automation
energy
enterprise
software
|
Stem, Inc.
|
2.2x
|
0.40
|
Stem can roughly double revenue by making PowerTrack a stickier operating layer for solar, storage, and hybrid fleets, but the stock outcome will be governed less by AI narrative than by whether recurring ARR compounds fast enough to outrun leverage and dilution.
|
| 80 |
TSM
|
ai
automation
hardware
semiconductors
|
Taiwan Semiconductor Manufacturing Company Limited
|
2.2x
|
0.88
|
TSMC should remain the scarce execution point for AI compute: it controls the hardest-to-replicate mix of leading-edge wafers, advanced packaging, yield learning and ecosystem trust, so even with huge capex and geopolitical drag it can outgrow the broader semiconductor stack and roughly double equity value by 2031.
|
| 81 |
PL
|
ai
defense
enterprise
software
space
|
Planet Labs PBC
|
2.1x
|
0.70
|
Planet can evolve from an imagery vendor into a sovereign geospatial infrastructure layer: scarce daily Earth data plus API workflow embedding plus Swedish-style satellite services can drive >4x revenue by 2031, but today’s premium valuation likely caps equity upside closer to 2x unless higher-value software and network effects become clearly repeatable.
|
| 82 |
RKLB
|
aerospace
defense
hardware
software
space
|
Rocket Lab Corporation
|
2.1x
|
0.60
|
AI-era defense, Earth observation, and orbital infrastructure demand should expand the market, and Rocket Lab owns real control points in launch access, flight heritage, and integrated mission hardware. Over five years the business can grow sharply, but shareholder upside is capped by an already rich valuation unless Neutron converts that broader stack into much larger revenue.
|
| 83 |
CLS
|
ai
cloud
communications
hardware
networking
|
Celestica Inc.
|
2.1x
|
0.62
|
Celestica is one of the cleaner ways to own AI infrastructure scaling without betting on a single chip vendor: if it converts its 2026-2027 capacity build into durable hyperscaler and regulated-market share, revenue can compound well beyond legacy EMS norms even with some multiple compression.
|
| 84 |
KTOS
|
aerospace
automation
communications
defense
space
|
Kratos Defense & Security Solutions, Inc.
|
2.1x
|
0.64
|
Kratos can turn self-funded positions in affordable drones, propulsion, microwave electronics, and software-defined ground systems into a much larger production platform by 2031; the upside comes from funded volume, recurring readiness layers, and allied distribution, while the hard limits are appropriations timing, factory throughput, and a valuation that already discounts real success.
|
| 85 |
NET
|
ai
cloud
cybersecurity
networking
software
|
Cloudflare, Inc.
|
2.1x
|
0.72
|
Cloudflare owns a valuable control point in the Internet traffic path, so AI-driven growth in applications, agents, and API traffic should expand demand for its security, networking, and developer stack; if reliability improves, that can drive deeper consolidation and selective new trust-layer monetization.
|
| 86 |
RMBS
|
ai
cybersecurity
hardware
semiconductors
|
Rambus Inc.
|
2.1x
|
0.66
|
Rambus is a leveraged way to own the AI memory bottleneck: qualified memory-interface chip content plus royalty-rich interface and security IP can compound well above semiconductor averages, while its cash-rich, fabless model keeps capital needs modest.
|
| 87 |
SNPS
|
ai
automation
enterprise
semiconductors
software
|
Synopsys, Inc.
|
2.1x
|
0.78
|
Synopsys should compound from a dominant EDA and IP base into a broader silicon-to-systems workflow owner; AI raises verification, simulation, and traceability demand faster than it commoditizes seats, so integration with Ansys plus debt paydown can drive roughly 2x equity value by 2031.
|
| 88 |
AMZN
|
advertising
ai
cloud
enterprise
transportation
|
Amazon.com, Inc.
|
2.1x
|
0.78
|
Amazon is one of the few companies that can monetize AI twice: first as AWS compute and governed model infrastructure, then as Prime-led commerce, ads, and seller tools. If its capex wave turns into higher-mix recurring revenue and it keeps the transaction rail relevant in an agentic world, value can compound above normal mega-cap expectations.
|
| 89 |
CEG
|
ai
energy
enterprise
nuclear
|
Constellation Energy Corporation
|
2.1x
|
0.80
|
Post-Calpine, Constellation controls one of the scarcest AI-era inputs: reliable, interconnection-ready clean power. If it converts that scarcity into more long-dated contracts, site-control economics, and selective restart/uprate capacity, the equity can still roughly double by 2031 despite its already large size.
|
| 90 |
COHR
|
ai
communications
hardware
networking
semiconductors
|
Coherent Corp.
|
2.1x
|
0.68
|
Coherent sits on a real AI bottleneck—optical bandwidth, lasers and qualified photonics capacity—not a software wrapper; if it converts today’s booked demand into reliable InP, transceiver and later CPO output, revenue can more than double and the equity can still roughly double despite an already rich rerating.
|
| 91 |
NVDA
|
ai
hardware
networking
semiconductors
software
|
NVIDIA Corporation
|
2.1x
|
0.93
|
NVIDIA still owns the main tollbooths of the AI buildout—accelerators, networking, systems, and developer software—so even with export limits and custom-chip pressure, a very large revenue and cash-flow expansion remains plausible by 2031; the stock can still roughly double, but size now caps the upside.
|
| 92 |
PANW
|
ai
cloud
cybersecurity
enterprise
software
|
Palo Alto Networks, Inc.
|
2.1x
|
0.74
|
Palo Alto Networks is shifting from a firewall vendor to a broad enterprise trust layer across network, cloud, SOC, identity, and AI workflows; if integration stays clean, AI-driven attack-surface growth and security consolidation can keep revenue compounding faster than mature software peers, though the starting valuation caps upside to a strong double rather than a moonshot.
|
| 93 |
ANET
|
ai
cloud
hardware
networking
software
|
Arista Networks, Inc.
|
2.0x
|
0.74
|
Arista is a premium AI-era networking control point: if open Ethernet keeps winning AI fabrics and Arista converts more of its installed base into software, campus, routing, and verification revenue, sales can outgrow the market even while the stock's multiple matures.
|
| 94 |
MU
|
ai
cloud
enterprise
hardware
semiconductors
|
Micron Technology, Inc.
|
2.0x
|
0.70
|
Micron is one of the few public ways to own AI memory scarcity directly: if it converts today’s HBM-driven shortage into durable mix improvement, contracted supply economics and better cycle discipline, revenue can roughly double by 2031; the catch is that much of the easy re-rating is already in the stock.
|
| 95 |
ARM
|
ai
automotive
cloud
hardware
semiconductors
|
Arm Holdings plc
|
2.0x
|
0.74
|
Arm is a scarce, capital-light toll collector on AI-era compute growth: if it keeps moving from core IP to higher-value subsystem and server content, royalties can compound far faster than semiconductor unit growth and support roughly a doubling in equity value by 2031.
|
| 96 |
FN
|
automation
communications
hardware
networking
|
Fabrinet
|
2.0x
|
0.58
|
Fabrinet should compound through 2031 because AI-scale optical links, telecom recovery, and HPC outsourcing are pushing scarce, qualified photonics manufacturing capacity into short supply; Building 10, Pinehurst, and selective service-layer monetization can roughly double revenue, though OEM buyer power keeps the ceiling below frontier semiconductor economics.
|
| 97 |
MSFT
|
ai
cloud
cybersecurity
enterprise
software
|
Microsoft Corporation
|
2.0x
|
0.86
|
Microsoft is one of the few incumbents that can turn AI from a feature race into broader control of enterprise workflows, permissions, and compute spend; if Azure capacity keeps catching up and monetization shifts toward governed, metered work rather than just add-on seats, a roughly 2x equity outcome by 2031 is plausible even with some valuation compression.
|
| 98 |
MTSI
|
communications
defense
hardware
networking
semiconductors
|
MACOM Technology Solutions Holdings, Inc.
|
2.0x
|
0.70
|
MACOM is a leveraged second-derivative on AI infrastructure: if it keeps qualifying higher-speed optical and copper links, improves internal fab throughput, and monetizes trusted manufacturing in defense, it can compound well above analog peers even though the stock already prices in real success.
|
| 99 |
ON
|
automation
automotive
energy
hardware
semiconductors
|
ON Semiconductor Corporation
|
2.0x
|
0.65
|
onsemi is a cyclical power semiconductor company with a credible path to roughly double enterprise value by 2031 if factory loading normalizes, AI rack power becomes a real second growth leg, and Treo-, GaN- and sensing-led mix shifts restore a higher-quality margin profile.
|
| 100 |
PWR
|
automation
communications
energy
|
Quanta Services, Inc.
|
2.0x
|
0.72
|
Quanta is a scarce execution network sitting on the AI-era power bottleneck: if it can keep scaling labor, equipment access and contract discipline, it should convert grid, generation and large-load demand into years of above-market growth, though the stock already prices in much of that scarcity.
|
| 101 |
SITM
|
ai
communications
hardware
networking
semiconductors
|
SiTime Corporation
|
2.0x
|
0.60
|
SiTime is a differentiated precision-timing supplier whose revenue can scale non-linearly if AI datacenter demand stays strong and the Renesas timing deal closes, but the stock already prices in scarcity, so operating upside is likely to translate into solid rather than explosive shareholder returns.
|
| 102 |
AVGO
|
ai
cloud
networking
semiconductors
software
|
Broadcom Inc.
|
2.0x
|
0.80
|
Broadcom remains an AI-era toll booth: custom silicon, Ethernet networking and sticky private-cloud software let it capture expanding hyperscaler and enterprise AI spend, while strong cash flow helps lock scarce supply, reduce leverage and support buybacks. From this reset share price, a roughly 2x equity outcome by 2031 is still plausible, driven more by revenue compounding than by multiple expansion.
|
| 103 |
CDNS
|
ai
enterprise
hardware
semiconductors
software
|
Cadence Design Systems, Inc.
|
2.0x
|
0.76
|
Cadence should remain an AI-era toll collector on rising chip and system complexity: cheaper design cognition drives more verification, emulation, IP and multiphysics work through its trusted workflows, lifting revenue materially, though the stock’s starting valuation likely caps returns to strong compounding rather than hypergrowth.
|
| 104 |
MPWR
|
ai
automotive
cloud
hardware
semiconductors
|
Monolithic Power Systems, Inc.
|
2.0x
|
0.65
|
MPS is a high-quality AI-power enabler whose best 5-year path is sustained socket wins in enterprise data and automotive, plus a mix shift into denser modules and system content; the key debate is not demand, but whether supply control and premium pricing can keep pace with the opportunity.
|
| 105 |
VRT
|
ai
automation
cloud
energy
hardware
|
Vertiv Holdings Co
|
2.0x
|
0.80
|
Vertiv is a high-quality AI infrastructure toll booth: if it keeps converting backlog into shipments, raises power-and-cooling content per deployment, and deepens lifecycle service attach, revenue can more than double by 2031, but today’s premium valuation likely caps shareholder returns to high-single-digit rather than venture-style outcomes.
|
| 106 |
CRWD
|
ai
cloud
cybersecurity
enterprise
software
|
CrowdStrike Holdings, Inc.
|
1.9x
|
0.70
|
CrowdStrike should remain a leading cybersecurity consolidator as AI expands the attack surface and raises the value of trusted telemetry, identity and response control, but shareholder upside is capped by a rich starting valuation and the need to fully normalize trust after the 2024 incident.
|
| 107 |
NTAP
|
ai
cloud
enterprise
hardware
software
|
NetApp, Inc.
|
1.9x
|
0.60
|
NetApp is a credible AI-era data-control compounder: if it keeps shifting mix toward all-flash, first-party cloud storage, and higher-value trust/compliance layers on top of ONTAP, revenue can grow high single digits and enterprise value can roughly double by 2031 without needing heroic market-share gains.
|
| 108 |
PLTR
|
ai
cloud
defense
enterprise
software
|
Palantir Technologies Inc.
|
1.9x
|
0.70
|
Palantir can still compound revenue at an exceptional rate through 2031 because it sells the governed workflow layer for real-world AI deployment, but the stock already discounts so much success that strong business execution likely translates into solid, not explosive, shareholder returns.
|
| 109 |
BWXT
|
defense
energy
healthcare
nuclear
|
BWX Technologies, Inc.
|
1.9x
|
0.78
|
BWXT is a scarce public tollbooth on naval nuclear, special materials and commercial nuclear rebuilding; if it converts backlog and monetizes licensed fuel and component capacity, revenue can roughly double by 2031 even with some multiple compression.
|
| 110 |
GOOG
|
advertising
ai
cloud
enterprise
media
|
Alphabet Inc.
|
1.9x
|
0.78
|
Alphabet should keep compounding through 2031 because AI strengthens its owned distribution, cloud, and security stack faster than it erodes Search, but the likely outcome is durable high-single-digit to low-double-digit value growth rather than a step-change rerating because capex, regulation, and agent-led query shifts cap the upside.
|
| 111 |
ASML
|
automation
hardware
semiconductors
software
|
ASML Holding N.V.
|
1.9x
|
0.85
|
ASML should keep compounding as AI raises the number and value of advanced lithography steps per wafer, but shareholder upside is limited more by an already-premium starting valuation and policy/supply bottlenecks than by competitive obsolescence.
|
| 112 |
DELL
|
ai
cloud
enterprise
hardware
networking
|
Dell Technologies Inc.
|
1.9x
|
0.55
|
Dell is not the AI choke-point owner, but it is a scaled integrator sitting in front of a real bottleneck: turning scarce accelerators, storage and deployment work into live enterprise clusters. If it converts backlog, preserves attach and keeps using financing and support to lock in refresh cycles, the equity can roughly double by 2031 without needing a heroic rerating.
|
| 113 |
TLN
|
ai
energy
nuclear
|
Talen Energy Corporation
|
1.9x
|
0.74
|
Talen sits at a key AI bottleneck—scarce delivered power in PJM—and can convert a merchant fleet into a higher-quality compute-energy platform if it closes Cornerstone, expands contracted large-load exposure, and delevers fast enough to preserve capital flexibility.
|
| 114 |
VST
|
energy
nuclear
|
Vistra Corp.
|
1.9x
|
0.70
|
Vistra is moving from a mainly merchant power story toward a scarcer, contract-backed reliability platform; if it closes Cogentrix, ramps Meta and AWS, and monetizes firm power for AI load without overlevering, 2031 cash flow can outgrow revenue and support roughly a doubling of equity value.
|
| 115 |
JBL
|
ai
automation
hardware
healthcare
networking
|
Jabil Inc.
|
1.8x
|
0.60
|
Jabil is shifting from a plain-vanilla contract manufacturer toward a higher-value AI infrastructure and regulated-industries operator; if rack, power, cooling, and lifecycle services keep lifting mix, revenue can reach 50000 by 2031 and the equity can compound at a low-teens rate without needing a heroic multiple.
|
| 116 |
LITE
|
ai
communications
hardware
networking
semiconductors
|
Lumentum Holdings Inc.
|
1.7x
|
0.72
|
Lumentum is shifting from a cyclical optics supplier toward a scarce AI-networking bottleneck vendor, but the stock already reflects much of that shift; the 5-year case depends on scaling high-speed lasers, transceivers and optical switching faster than capacity and pricing normalize.
|
| 117 |
EQIX
|
ai
cloud
enterprise
networking
|
Equinix, Inc.
|
1.7x
|
0.80
|
Equinix should keep compounding because AI makes scarce metro power, neutral interconnection and embedded infrastructure workflows more valuable, but the stock already prices much of that edge, so the likely outcome is premium compounding rather than hypergrowth.
|
| 118 |
ETN
|
aerospace
automation
cybersecurity
energy
hardware
|
Eaton Corporation plc
|
1.7x
|
0.72
|
Eaton owns hard-to-replace power-chain bottlenecks just as AI campuses, grid hardening and aerospace demand lift system complexity; that should support durable above-market growth, but its size and already-premium valuation likely keep the equity outcome in strong compounding territory rather than true hypergrowth.
|
| 119 |
HPE
|
cloud
enterprise
hardware
networking
software
|
Hewlett Packard Enterprise Company
|
1.6x
|
0.48
|
HPE is a credible AI-era enterprise infrastructure consolidator: if Juniper expands networking mix, AI backlog converts cleanly, and GreenLake deepens workflow control, the company can compound equity at a low-double-digit rate without needing a frontier-AI valuation.
|
| 120 |
NEE
|
ai
energy
nuclear
|
NextEra Energy, Inc.
|
1.4x
|
0.76
|
NextEra should keep compounding as one of the few U.S. power companies with both a protected utility franchise and a national AI-load development engine, but the likely payoff is durable premium utility growth rather than explosive re-rating because funding needs remain heavy.
|